Screener examples › Sectors & Themes
Biotech below cash
Pipelines priced at less than cash.
“Biotech companies whose market cap is less than their cash and equivalents”
Run this screen live and refine it in plain English (free, no sign-up).
US biotechnology companies whose market cap is below their cash and equivalents, ranked by cash-to-market-cap ratio.
Filters: Industry = Biotechnology; Market cap < cash and equivalents; Market cap > 0
Top matches on data as of October 26, 2026
| Symbol | Company | Industry | Market Cap (USD) | Market Cap | Cash | Total Debt | Net Debt | EV | Price |
|---|---|---|---|---|---|---|---|---|---|
| CMND | Clearmind Medicine Inc. | Biotechnology | $1.2M | $1.2M | $11.4M | $1.3M | $-10.1M | $-8.9M | $6.12 |
| CRIS | Curis, Inc. | Biotechnology | $805877.33 | $805877.33 | $5.6M | $1.0M | $-4.6M | $-3.8M | $0.38 |
| ONCO | Onconetix, Inc. | Biotechnology | $895089.51 | $895089.51 | $5.9M | $187128.00 | $-5.8M | $-4.9M | $0.40 |
| VTGN | VistaGen Therapeutics, Inc. | Biotechnology | $6.9M | $6.9M | $45.4M | $1.0M | $-44.4M | $-37.5M | $0.17 |
| ARTL | Artelo Biosciences, Inc. | Biotechnology | $662932.60 | $662932.60 | $4.2M | $49000.00 | $-4.1M | $-3.5M | $2.20 |
| MBIO | Mustang Bio, Inc. | Biotechnology | $2.4M | $2.4M | $15.2M | $0.00 | $-15.2M | $-12.7M | $0.36 |
| SPRC | SciSparc Ltd. | Biotechnology | $714287.19 | $714287.19 | $4.4M | $2.7M | $-1.8M | $-1.0M | $1.29 |
| BBLG | Bone Biologics Corporation | Biotechnology | $677376.64 | $677376.64 | $4.0M | $0.00 | $-4.0M | $-3.4M | $0.38 |
| NCNA | NuCana plc | Biotechnology | $4.4M | $4.4M | $25.8M | $889720.11 | $-24.9M | $-20.6M | $1.04 |
| REVB | Revelation Biosciences, Inc. | Biotechnology | $1.9M | $1.9M | $11.5M | $739916.00 | $-10.7M | $-8.8M | $3.54 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Biotechnology | $31.6M | $31.6M | $180.5M | $22.4M | $-158.1M | $-126.5M | $0.37 |
| APVO | Aptevo Therapeutics Inc. | Biotechnology | $1.8M | $1.8M | $9.8M | $4.2M | $-5.6M | $-3.8M | $1.50 |
| RNAZ | TransCode Therapeutics, Inc. | Biotechnology | $1.6M | $1.6M | $8.4M | $652411.00 | $-7.7M | $-6.1M | $1.71 |
| KYNB | Kyntra Bio, Inc. | Biotechnology | $18.2M | $18.2M | $91.3M | $0.00 | $-91.3M | $-73.1M | $4.50 |
| KPTI | Karyopharm Therapeutics Inc. | Biotechnology | $14.0M | $14.0M | $65.1M | $215.9M | $150.8M | $164.7M | $0.48 |
| CLDI | Calidi Biotherapeutics, Inc. | Biotechnology | $906240.00 | $906240.00 | $4.1M | $1.9M | $-2.1M | $-1.2M | $0.64 |
| SILO | Silo Pharma, Inc. | Biotechnology | $1.3M | $1.3M | $5.4M | $0.00 | $-5.4M | $-4.2M | $1.16 |
| CALC | CalciMedica, Inc. | Biotechnology | $4.4M | $4.4M | $18.6M | $0.00 | $-18.6M | $-14.2M | $1.30 |
| MGX | Metagenomi, Inc. Common Stock | Biotechnology | $28.9M | $28.9M | $120.7M | $37.7M | $-82.9M | $-54.0M | $0.77 |
| TCRX | TScan Therapeutics, Inc. | Biotechnology | $24.7M | $24.7M | $100.2M | $90.9M | $-9.3M | $15.4M | $0.19 |
| GRI | GRI Bio, Inc. | Biotechnology | $2.7M | $2.7M | $10.9M | $44000.00 | $-10.9M | $-8.2M | $1.50 |
| MDCX | Medicus Pharma Ltd. Common Stock | Biotechnology | $2.8M | $2.8M | $10.7M | $15.3M | $4.6M | $7.3M | $2.51 |
| ATYR | aTyr Pharma, Inc. | Biotechnology | $15.0M | $15.0M | $57.4M | $11.3M | $-46.1M | $-31.1M | $0.15 |
| MBRX | Moleculin Biotech, Inc. | Biotechnology | $2.0M | $2.0M | $7.3M | $292000.00 | $-7.0M | $-5.0M | $7.09 |
| AIM | AIM ImmunoTech Inc. | Biotechnology | $2.8M | $2.8M | $10.0M | $3.9M | $-6.0M | $-3.2M | $0.16 |
25 matches. Research data, not investment advice.